NFSG
PTCT icon

Newbridge Financial Services Group’s PTC Therapeutics PTCT Stock Holding History

Newbridge Financial Services Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-34
Closed -$762 – 1295
2023
Q3 		$762 Hold
34
– – ﹤0.01% 1176
2023
Q2 		$1.38K Hold
34
– – ﹤0.01% 1179
2023
Q1 		$1.65K Hold
34
– – ﹤0.01% 1227
2022
Q4 		$1.3K Hold
34
– – ﹤0.01% 1276
2022
Q3 		$2K Hold
34
– – ﹤0.01% 1222
2022
Q2 		$1K Hold
34
– – ﹤0.01% 1297
2022
Q1 		$1K Hold
34
– – ﹤0.01% 1395
2021
Q4 		$1K Hold
34
– – ﹤0.01% 1352
2021
Q3 		$1K Hold
34
– – ﹤0.01% 1298
2021
Q2 		$1K Hold
34
– – ﹤0.01% 1383
2021
Q1 		$2K Buy
+34
New +$2.02K ﹤0.01% 1188

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Newbridge Financial Services Group's PTCT Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of PTC Therapeutics (PTCT) in Q4 2023, closing a stake of 34 shares — an estimated $762 sold.

Newbridge Financial Services Group first reported a position in PTCT in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q3 2022. 172 funds tracked by Wall St. Rank hold PTCT as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining PTC Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 34 PTC Therapeutics shares in Q4 2023, an estimated $762.
  • Newbridge Financial Services Group first reported a position in PTC Therapeutics in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's PTC Therapeutics position peaked at $2K in Q3 2022.
  • 172 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.